Medicenna Therapeutics Corp
NASDAQ:MDNA
Medicenna Therapeutics Corp Stock, NASDAQ:MDNA
2 Bloor Street West, 7th floor, Toronto, Ontario M4W 3E2
Phone: +1.416.648.5555
Number of Employees: 7
Description
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.